Product Information
ZOLPIDEM TARTRATE 5 MG TABLET is a generic product labeled by ACI Healthcare USA Inc., priced at $0.0344 per EA under NDC 71093015504. Its NADAC has been published 313 times since Oct 7, 2020.
FDA first approved this application on Apr 23, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
ACI Healthcare USA Inc.NDC
71093015504
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077214FDA Approved
4/23/2007
TE Code
AB
On Market Since
9/24/2020
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TARTRATE 5 MG TABLET has been published 313 times since Oct 7, 2020, and over the history we have for it it has risen 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0344 per EA |
|---|---|
| All-time high | $0.0381 (Sep 13, 2023) |
| All-time low | $0.0249 (Nov 20, 2024) |
| 52-week high | $0.0348 |
| 52-week low | $0.0336 |
| Median price | $0.0331 |
| Average price | $0.0322 |
| Largest weekly change | +35.9% (Jan 18, 2023) |
| Weeks tracked | 313 |
| Tracking since | Oct 7, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ACI Healthcare USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TARTRATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TARTRATE 5 MG TABLET, manufactured by ACI Healthcare USA Inc., is $0.0344 per EA (NDC 71093015504), effective Sep 30, 2026.
How has the price of ZOLPIDEM TARTRATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TARTRATE 5 MG TABLET has risen 33.5%. It has been tracked across 313 weekly CMS publications since Oct 7, 2020.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TARTRATE 5 MG TABLET?
Since Oct 7, 2020, the NADAC for ZOLPIDEM TARTRATE 5 MG TABLET has ranged from a low of $0.0249 (Nov 20, 2024) to a high of $0.0381 (Sep 13, 2023), with a median of $0.0331 per EA.
Are there cheaper alternatives to ZOLPIDEM TARTRATE 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLPIDEM TARTRATE 5 MG TABLET, is $0.0294 per EA — about 14% below ZOLPIDEM TARTRATE 5 MG TABLET.
Who manufactures ZOLPIDEM TARTRATE 5 MG TABLET?
ZOLPIDEM TARTRATE 5 MG TABLET (NDC 71093015504) is labeled by ACI Healthcare USA Inc., and CMS classifies it as a generic product.